S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling

N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression

(2012) Hyereen Kang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression

(2012) Shang-Jyh Kao et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways

(2011) M. W. Nasser et al.   CANCER RESEARCH

The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)

(2011) Sonia Dutta et al.   GYNECOLOGIC ONCOLOGY

Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression

(2010) Shoshana Greenberger et al.   ANGIOGENESIS

Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression

(2010) Hui Ling et al.   BREAST CANCER RESEARCH AND TREATMENT

Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma

(2010) A Nishimura et al.   CANCER GENE THERAPY

S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer

(2010) N R West et al.   ONCOGENE

A small molecule inhibitor of NF-κB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells

(2009) Jason Ho Ting Wong et al.   CANCER LETTERS

S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation

(2008) Vikram Paruchuri et al.   PLoS One